# Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer (mirPANC 2)

> **NCT06945978** · — · RECRUITING · sponsor: **Benedito Mauro Rossi** · enrollment: 60 (estimated)

## Conditions studied

- Pancreatic Cancer
- Metastasis
- Epigenetic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06945978
- **Lead sponsor:** Benedito Mauro Rossi
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-21
- **Primary completion:** 2027-10
- **Final completion:** 2027-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06945978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06945978, "Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer (mirPANC 2)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06945978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*